M Cwiklinska
Overview
Explore the profile of M Cwiklinska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guzowski J, Buda R, Costantini M, Cwiklinska M, Garstecki P, Stone H
Soft Matter
. 2022 Feb;
18(9):1801-1818.
PMID: 35166293
We study the dynamics of threads of monodisperse droplets, including droplet chains and multi-chains, in which the droplets are interconnected by capillary bridges of another immiscible liquid phase. This system...
2.
Lukaszewicz A, Niechoda A, Zarzecki M, Cwiklinska M, Holownia A
Adv Exp Med Biol
. 2020 Jan;
1271:61-68.
PMID: 31925751
The ability of air particulate matter (PM) to cause reactive oxygen species-driven protein damage is associated with both COPD and lung cancer, but the mechanisms are unsettled. In this study,...
3.
Lukaszewicz A, Cwiklinska M, Zarzecki M, Szoka P, Lachowicz J, Holownia A
Adv Exp Med Biol
. 2019 Jun;
1176:101-108.
PMID: 31175637
Exposure to urban airborne particulate matter (PM) associates with adverse health effects, but the exact mechanisms remain unclear. In this study, we focused on cytotoxicity (MTT), oxidative stress (DCF/FC), DNA...
4.
Szoka P, Lachowicz J, Cwiklinska M, Lukaszewicz A, Rybak A, Baranowska U, et al.
Adv Exp Med Biol
. 2019 Apr;
1176:63-69.
PMID: 31016633
Chronic exposure to cigarette smoke (CS) causes structural and functional changes in the respiratory tract. It is a major risk factor for cardiovascular and systemic pulmonary diseases. The aim of...
5.
Cwiklinska M, Teresinski G, Buszewicz G
Arch Med Sadowej Kryminol
. 2015 Aug;
65(2):77-89.
PMID: 26284966
Introduction: The available legal regulations in Poland do not define the concentration thresholds enabling to differentiate between the states of "after-use" versus "under the influence" of a drug, as it...
6.
Cywka T, Teresinski G, Cwiklinska M, Buszewicz G, Matysiak P
Arch Med Sadowej Kryminol
. 2014 Sep;
64(1):8-19.
PMID: 25184423
Unlabelled: The situations in which autopsy blood toxicology results do not confirm methanol and/or ethylene glycol intoxications diagnosed during patients` hospitalizations are frequently observed in the Department of Forensic Medicine...
7.
Chybicka A, Kalwak K, BOGUSLAWSKA-JAWORSKA J, Turkiewicz D, Armata J, Balcerska A, et al.
Med Wieku Rozwoj
. 2002 May;
4(1 Suppl 2):49-55.
PMID: 12021462
Retrospective analysis of 102 children with CML from 9 paediatric centres in Poland has been performed. A total number of 102 children: 58 boys and 44 girls aged 1-17 years...
8.
Chybicka A, BOGUSLAWSKA-JAWORSKA J, Kalwak K, Turkiewicz D, Armata J, Balcerska A, et al.
Wiad Lek
. 2000 Mar;
51 Suppl 4:33-9.
PMID: 10731941
94 children with chronic myelocytic leukaemia--CML treated in period 1975-1998 were included in the study. Twenty seven of 60 children were treated with hydroxyurea or busulfan with 6 MP. In...
9.
Zaleska-Czepko E, Cwiklinska M, Balwierz W, Armata J
Pediatr Hematol Oncol
. 1996 Mar;
13(2):191-3.
PMID: 8721037
No abstract available.
10.
Cwiklinska M, Balwierz W, Armata J, Zaleska-Czepko E
Pediatr Pol
. 1995 Nov;
70(11):981-3.
PMID: 8677167
Successful treatment of olfactory neuroblastoma is more often described in less advanced tumors and mostly in adults. Fewer presentations concern successful chemotherapy in advanced stages of the disease.